Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :2735
Small font sizeDefault font sizeIncrease font size
Navigate here
 » Next article
 » Previous article 
 » Table of Contents
Resource links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »  Article in PDF (690 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)  

  In this article
 »  Abstract
 »  Introduction
 »  Materials and Me...
 »  Results
 »  Discussion
 »  Acknowledgments
 »  References
 »  Article Tables

 Article Access Statistics
    PDF Downloaded700    
    Comments [Add]    
    Cited by others 33    

Recommend this journal


Year : 2009  |  Volume : 46  |  Issue : 4  |  Page : 297-302

Lipid peroxidation and antioxidants in different stages of cervical cancer: Prognostic significance

1 Department of Pathology, C. S. M. Medical University, Lucknow, India
2 S.G.P.G.I. Lucknow, India
3 Department of Obstetrics - Gynecology, C. S. M. Medical University, Lucknow, India
4 Departments of Statistics, Lucknow University, India

Date of Web Publication9-Sep-2009

Correspondence Address:
A N Srivastava
Department of Pathology, C. S. M. Medical University, Lucknow
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-509X.55549

Rights and Permissions

 » Abstract 

Background: Free radical Injury is associated with cancer, but how the extent of oxidative stress correlates with the FIGO (International Federation of Gynecology and Obstetrics) stage in Carcinoma Cervix (Ca Cx), and its significance as a prognostic marker, is not clear and needs an in-depth study. Aim: To correlate the blood levels of Lipid Peroxidation (LPO), Reduced Glutathione (GSH), Superoxide Dismutase (SOD), and Vitamin A and E levels with the clinical stage in Ca Cx. Settings and Design: This is a Prospective Case Control Study. Materials and Methods: LPO, SOD, reduced GSH were estimated by Bio Chemical Assays and Vitamins by High Performance Liquid Chromatography (HPLC). Statistical Analysis: The cases and controls were compared using One Way ANOVA and different stages over different time periods were individually compared by Repeated Measure Analysis of Variance. Results: The results indicated a statistically significant increase of LPO vis-a-vis the FIGO stage of Ca Cx and control, while the antioxidant status as depicted by GSH and SOD decreased. Vitamin A and E levels were significantly lower in cancer cases as compared to the control. Conclusion: Increased LPO and reduced antioxidant levels may be taken as associated predictive markers, thus suggesting that Ca Cx cases should get nutritive supplements to contain the blood LPO level and maintain a positive balance of antioxidants for a better outcome in terms of delayed recurrence and better Quality of Life (QOL).

Keywords: Antioxidants, cervical cancer, free radicals, prognosis

How to cite this article:
Srivastava S, Natu S M, Gupta A, Pal K A, Singh U, Agarwal G G, Singh U, Goel M M, Srivastava A N. Lipid peroxidation and antioxidants in different stages of cervical cancer: Prognostic significance. Indian J Cancer 2009;46:297-302

How to cite this URL:
Srivastava S, Natu S M, Gupta A, Pal K A, Singh U, Agarwal G G, Singh U, Goel M M, Srivastava A N. Lipid peroxidation and antioxidants in different stages of cervical cancer: Prognostic significance. Indian J Cancer [serial online] 2009 [cited 2022 Jul 6];46:297-302. Available from:

 » Introduction Top

Cervical cancer is the most prevalent genital tract cancer in the world, including India. [1],[2] It is a multifactorial disease process and several risk factors include, early age intercourse, multiple sex partners, low socioeconomic status, and Human papillomavirus (HPV) infection. [1],[2] Chronic inflammation and infection over a prolonged period of time have been recognized as major risk factor for disease initiation. [3]

Carcinoma in situ is but a phase leading to frank cancer. [4] Evidence has indicated that reactive oxygen species (ROS) are involved in the initiation and progression of carcinogenesis. This may be due to the damage caused to the tumor suppressor genes or immunological defenses in our body. [5] Superoxide and hydroxyl radicals are oxygen-free radicals, involved in producing oxidative stress. This oxidative stress can be associated with other factors which may lead to various neoplastic transformations. [6]

Deleterious effects of these oxidants are counteracted by antioxidants such as Superoxide dismutase (SOD), Glutathione peroxidase (GPX), and reduced glutathione (GSH). [7] In addition to the body's defense mechanism there are vitamins that provide the body with the much-needed immunity and a mechanism of self-defense to fight against various pathogens. Studies indicate that the level of these antioxidants in the body decrease in cases of carcinogenesis. The levels of vitamin E were found to vary in a study of cervical carcinogenesis. [8] Very few studies have given importance to different stages of cervical cancer as per FIGO staging/grading and degree of free radical damage correlations. The present study was therefore planned to study free radical injury levels and some antioxidants in the four stages of cervical cancer cases, before and after treatment.

 » Materials and Methods Top


Subjects included in this study comprised women attending the Out door Patients Department (OPD) of Obstetrics and Gynecology of our institution. Of the 356 registered patients suspected for cervical pathology;  Pap smear More Detailss of all the 356 cases were collected and after detection of cancer in the Pap smear reports and further confirmation by histopathological reports, (taken as Gold Standard) the cases were enrolled in the study. Any patient with a history of prior treatment for cancer or any previous associations with a chronic debilitating disease like HIV, TB, and so on were excluded from the study. Thus 95 cases were finally enrolled for this study. All these patients received radiation treatment, which was as follows:

  • The patients were given radiotherapy by External Beam Radiotherapy (EBRT) followed by brachytherapy. EBRT was delivered with the help of a telecobalt therapy machine (Theratron 780 E, AECL, Ottawa). A total dose of 50 Gy in 5 weeks 5 Fc per week, was delivered to the whole pelvis. This was followed by high dose rate (HDR) brachytherapy after a gap of 2 weeks after completion of EBRT. Patients were also given chemotherapy in the form of an injection, cisplatin 30 mg/m 2 IV weekly, throughout the course of EBRT, with IV hydration and antimetic prophylaxis. The stage wise distribution of all the cases enrolled was as follows: Stage I = 12, Stage II = 29, Stage III = 43, Stage IV = 11. Forty ladies, with no cervical pathology or any other cancer, were registered as control. Controls were healthy subjects, who after physical examination showed no symptoms of any debilitating disease or cervical lesions, and who consented to be a part of the study. The protocol of informed consent had already been approved by the Ethical Committee of Chattrapati Shahuji Maharaj Medical University. The control measuring was not paralled with that of the cases at different occasions, as the ethical committee did not permit any such repeated measurements.
Samples and schedule of sample collection

Venous blood samples of all these patients were collected in heparinzed tubes for separation of plasma and lysate, for bio-chemical assays. Five milliliters of venous blood samples were collected on Day '0', after 6-8 weeks, 6-8 months, and 1 year after starting the treatment. Serum, plasma, and haemolysate were separated from these blood samples. For plasma and haemolysate preparation blood was taken in the EDTA vials.

Estimation of lipid peroxide levels (LPO)

Blood plasma of 0.2 ml was mixed with 1 ml of 20% acetic acid; subsequently 0.2 ml of 8% SDS was added to the above mixture and pH was adjusted to 4. Following that, 1.5 ml of 0.8% TBA and 1.1 ml of distilled water was added. This reaction mixture was incubated in a boiling water bath for 1 hour. After cooling, 3 ml of n-butanol was mixed, and then centrifuged at 10,000 g for 15 minutes. A clear butanol fraction thus obtained was used for measuring the absorbance at 532 nm. [9]

Enzyme purification for reduced glutathione and superoxide dismutase

Haemolysate of 0.2 ml was mixed with 0.8 ml chilled water, 0.5 ml ethanol, and 0.25 ml chloroform. The mixture was stirred and kept for 15 minutes at 4˚C. It was then centrifuged at 3000 rpm for 15 minutes. The precipitate was discarded and the supernatant used for estimation of GSH and SOD. According to Tsuchihashi M (1923), [10] the precipitation step helps in the removal of hemoglobin from haemolysate. [11],[12],[13],[14]

Estimation of reduced glutathione (GSH)

One milliliter of the supernatant after ethanol and chloroform extraction as above was mixed with 1 ml DTNB reagent just before measuring the absorbance of the sample at 412 nm. GSH solution of known concentration was similarly processed to prepare a standard curve. The amount of GSH in the sample was determined from the standard curve. [15]

Estimation of superoxide dismutase (SOD)

The supernatant from the above extraction step was divided into two portions, Experimental and Reference. To the experimental test tube we added 0.3 ml Nitroblue tetrazolium (NBT), 0.2 ml Phenazine Metho Sulphate (PMS) and 0.2 ml pyrophosphate buffer, 1 ml D.D.W, and 2 ml enzyme for analysis. In the reference test tube, everything was added along with NADH except the enzyme.The reaction was run for 90 seconds at 37°C with constant stirring. The reaction was stopped by adding 1 ml acetic acid. After 10 minutes, the enzyme was added in the reference test tube and optical density (OD) was read at 560 nm. Blank included NBT, PMS Buffer, and Triple Distilled Water. [16]

Estimation of protein

Haemolysate was used for protein estimation. Haemolysate of 0.1 ml was taken and to this was added 0.9 ml of triple distilled water. Further, 1 ml 10% trichloroacetic acid was added and then kept at 4°C for 4 hours. After centrifugation at 4000 rpm for 15 minutes, the supernatant was discarded and the precipitate was dissolved in 2 ml 0.1 N NaOH. For protein estimation 0.1 ml of the sample was taken as protein. To this was added alkaline Cu reagent and incubated for 20 minutes at 37°C, then Folin's reagent was added and incubated at 37°C for 15 minutes. Bovine Serum Albumin (BSA) was used as a standard and OD was read at 660 nm. [17]

Estimation of vitamins

Vitamin A and E were measured by high performance liquid chromatography (HPLC) as per the modified method of Omu et al . [18] Briefly α -tocopherol acetate and retinol acetate were pipetted into an Eppendorf tube.To this, blood serum was added and vortex mixed; hexane extract of vitamins A and E was aspirated out into a glass tube, dried under nitrogen stream, and dissolved into methanol. Finally this preparation was injected into a HPLC, fitted with reverse phase of C 18 stainless steel column.The vitamins were eluted with methanol at a flow rate of 1.5 ml /min for 15 minutes.The peak heights and curve areas of vitamin A and E and their acetates were measured to calculate the amount of these vitamins in the blood with an ultraviolet detector with 292 nm filters. The levels of vitamin A and E were not planned for estimation at different occasions due to financial constraints of the study.

Statistical Analysis

At the time of the recruitment (occasion 1), five groups of subjects (control and four stages of cancer patients) were available, so one-way analysis of variance (ANOVA) was performed to test the equality of mean GSH, LPO, and SOD levels. The longitudinal observations were measured on four different occasions for four stages of cancer patients. To take into account the correlated behavior of longitudinal observations, the repeated measure analysis of variance was performed to compare the mean GSH, LPO, and SOD levels among the four groups as well as over four different occasions. The P-value of < 0.05 was taken to be significantly different. For the purpose of analysis we have defined the four time periods as Occasion 1: day '0', Occasion 2: as 6-8 weeks, Occasion 3: as 6-8 months and Occasion 4: as1 year.

 » Results Top

The results of LPO, GSH, and SOD in different stages of cervical cancer and that of healthy controls at day '0' are shown in [Table 1]. The results revealed increase in levels of LPO with higher stage of cervical cancer and the lowest levels were seen in the control group.

GSH and SOD in control samples showed higher values, which decreased significantly in the higher cancer stages.

The one-way ANOVA showed that the biochemical levels in [Table 1] and the level of vitamins in [Table 4] in all the four stages of cervical cancer patients as well as the control were significantly different ( P < 0.001). The differences were most significant for GSH (F-value = 770.0) followed by SOD (F-value = 339.6) and LPO (F-value = 67.0).

The patients were followed on four different occasions (day '0', 6-8 weeks, 6-8 months, and 1 year).The measurements were not paralleled with that of control for reasons explained earlier. The comparisons of four different stages for four different occasions are shown in [Table 2].

The mean GSH values showed a decreasing pattern for the four cancer stages as well as on the four occasions. The overall status was decreasing over the four time periods.

The mean SOD values as shown in [Table 2] decreased with stages and the decrease was also consistent for the different occasions. The overall values showed similar results as those for GSH.

The mean LPO levels showed an increasing pattern over the four stages on occasions 1 and 2. The same increasing pattern was observed over the four occasions for stage I, stage II, and stage III. However, in stage IV the LPO levels exhibited an inconsistent pattern on occasion 4.

The results of repeated measures of variance analysis with different time points as "within subject factor" and different stages of cancer as "between factors" are depicted in [Table 3]. All the three biochemical parameters were significantly different for the four stages of cancer ( P < 0.001). However, when the comparison was made on different occasions GSH and SOD levels were significantly different with P =0. 003 and P < 0.001, respectively. The LPO level on different occasions was not significant ( P = 0.15). These results are in coherence with the results of [Table 2], as discussed above.

Vitamin levels were significant, P < 0.001 when the values were compared with controls on day '0'.

 » Discussion Top

Cervical cancer is the most common cancer in women in developing countries. One of the main causes of this high prevalence is the lack of awareness in women for its early detection and management. A number of risk factors have been associated with cervical pre cancer and cancer. An extensive search over the past several years has suggested the role of free radicals in a number of diseases including carcinogenesis. [19] Although the body's own defense mechanism plays a crucial role to control the levels of these free radicals, the levels of antioxidants that counterbalance these oxidative radicals get impaired themselves. The present study was planned to detect the levels of LPO, SOD, GSH, and Vitamin A and E in cases of uterine cervical cancer in different FIGO stages I, II, III, and IV. Free radical detection was done in controls and patients at day '0', that is, before the start of the treatment. Later on, the measurements of LPO, GSH, and SOD were done after 6-8 weeks, after 6-8 months, and after one year of starting the treatment, in the same set of patients.

In the present study the values of LPO demonstrated higher levels in stages I to IV as compared to control and the differences were statistically significant. However repeated measure analysis of variance values at different intervals had an inconsistent pattern and there was statistically no significant difference at day '0', 6-8 weeks, 6-8 months, or a 1 year level.It appears that a saturation plateau was reached in Stage IV disease as far as the plasma circulating level of lipid peroxide was concerned.

Lipid Peroxidation is the oxidative conversion of polyunsaturated fatty acids to MDA (malondialdehyde); which is cytotoxic and acts as a tumor promoter and a co-carcinogenic agent. [3],[4],[5],[6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20] Damage caused by LPO impairs the functioning of the biological membrane and the continued damage leads to loss of membrane integrity. [21] Beevi et al . [22] observed increased plasma as well as erythrocyte MDA in patients with cervical cancer, although there was no significant variation in lipid peroxides according to the stage of the tumor in their study.

Manju et al. [23] and Kim et al. , [24] have similarly demonstrated the involvement of rising LPO and compromised antioxidant levels. Ahmed et al [25] in their study demonstrated an overall progressive impaired status of antioxidants in Ca Cx. Manoharan et al. [26] have demonstrated enhanced erythrocyte LPO and impaired antioxidant enzyme activities, suggesting avenues for exploring damage to the red cell membrane structure and function in cervical cancer.

An analysis of reduced GSH in comparison to control showed consistent low values. The patients demonstrated significant decrease of reduced GSH levels from day '0' to 6-8 weeks, 6-8 months and finally up to 1 year. Pejic et al [7] have shown in their study a similar observation about high levels of lipid peroxides and markedly reduced levels in various gynecological conditions including cancer and have shown significant decrease of GSH level as well. Depleted levels of GSH in cervical cancer cases may be related to the reduction in activity of glucose-6-phosphate dehydrogenase in cervical cancer patients. [16] Nicotinamide Adenosine Dinucleotide Phosphate (NADPH) produced by the catalyst glucose-6-phosphate dehydrogenase plays an important role in the reduction of oxidized GSH to reduced GSH. [27]

This study revealed a very consistent reduction in the levels of SOD as compared to the control in all the stages at the time of patient recruitment. At different occasions, that is, at day '0', 6-8 weeks, 6-8 months and 1 year statistically significant lowering of SOD levels were seen.

Vitamin A is a known antioxidant which is especially responsible for healthy development and upkeep of the epithelium. Deficiency of vitamin A exposes the patient to further affects of oxidative stress, inhibiting any cell repair and return to normalcy. The levels of vitamin A in our studies showed a statistically significant diminution between various stages of cervical cancer from Stage I to Stage IV. This shall be an interesting idea to differentially investigate antioxidants and vitamin A in various stages of cervical cancer at day '0' levels and compare it with levels at various intervals in groups of patients who received vitamin A and in those who did not receive it. This may possibly also reveal differences in the levels of antioxidant status in terms of SOD, GSH, and so on.

Manju et al., [23] demonstrated a significantly diminished value for vitamin E level along with reduction in other antioxidants such as GSH, GPX, and SOD, and attributed this reduction to the increased utilization in scavenging lipid peroxides as well as their sequestration by tumor cells. Their case control study was limited to a group of cervical cancer cases en-block (without any stagewise differentiation), whereas, in the present study the levels of vitamin E were studied in different stages of cervical cancer and showed a consistent difference among stages I, II, III, and IV, when mutually compared..Ahmed et al (1999) have shown that oxygen free radical levels are raised in cervical dysplasia and cervical cancer as compared to controls. [25] There are only a few studies showing FIGO stagewise measurements of vitamin E / vitamin C and other antioxidants in cervical cancer cases to correlate these findings. [23],[24],[25],[26],[27],[28] The present study fills this gap to some extent and documents FIGO stagewise levels in SOD, GSH, and vitamin A and E. The higher the FIGO stage the lower the level of antioxidants in blood. Other factors remaining same, the most important factor that can influence the levels of antioxidants in blood is the poor socioeconomic status of the patients, responsible for deficient nutrient intake. In the present study > 95% of patients was of lower middle class, thus eliminating this confounder.

In summary we can say that LPO is high in cases of cervical cancer as compared to controls when measured at day '0' and is statistically significant, although on different later occasions the levels become statistically insignificant. The levels of SOD and reduced GSH, which are already low on day '0', further dip down significantly at higher stages of cancer and this decrease is statistically significant. The levels of vitamin A and vitamin E show significant lower values in cancer patients and healthy controls on day '0' and the level dips as the stage of cancer gets higher.

This study gives the thought that carcinoma cervix cases, in addition to regular chemo-radiotherapy, may be given antioxidants to contain LPO levels, and to maintain a positive balance of antioxidants for better outcome in terms of delayed recurrence and better quality of life.

Further studies comprising larger series of patients are suggested to corroborate these findings.

 » Acknowledgments Top

The authors thank the Himalayan Drug Company, Bangalore, for partially financing this study.

 » References Top

1.Notani PN. Global variation in cancer incidence and mortality.Curr Sci 2001; 81:465-74.  Back to cited text no. 1    
2.Gajalaksmi C K, Krishnamurthy S, Ananth R, Shanta V. Cervical Cancer screening in tamilnadu, India: A feasibility study of training the village health nurse. Cancer Causes Control 1996; 7:520-24.  Back to cited text no. 2    
3.Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al . Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002;32:162-6.  Back to cited text no. 3    
4.Saraiya BU. Carcinoma- In situ of Cervix- Where the story Must End. ObstetGynecol Ind 2001;51:27-30.  Back to cited text no. 4    
5.Oshima H, Bartsch H. Chronic infection and inflammatory process as cancer risk Factors: Possible role of nitric oxidative in carcinogenesis. Mutat Res 1994;305:253-64.  Back to cited text no. 5    
6.Halliell B. Antoxidant in human health and diseases. Annu Rev Nutr 1996; 16:33-50.  Back to cited text no. 6    
7.Snezzana P, Jelena K, Ana T, Vesna S, Snezana B P. Lipid Peroxidation and antioxidant status in blood of patients with uterine myoma, endometrial polypus, Hyper plastic and malignant endometrium. Biol Res 2006; 39:619-29.   Back to cited text no. 7    
8.Khanna S, Nikunj N, Khanna HD. A Study of Antioxidants and their preventive potentialo in cervical dysplasia. Asian Journal of Obs and Gynae. Practice 2002; 6:20-4.   Back to cited text no. 8    
9.Ohkawa H, Ohisha N, Yagi K. Assay of lipid peroxides in animal tissue by Thiobarbituric acid reaction. Anal Biochem 1979; 5:351-8.   Back to cited text no. 9    
10.Tsuchihashi M. Zur Kenntnis der Blutkatalase. Biochem Z 1923; 140 :65-74.  Back to cited text no. 10    
11.Fidelis I, Achuba. Effect of Vitamins C and E Intake on Blood Lipid Concentration, Lipid Peroxidation, Superoxide Dismutase and Catalase Activities in Rabbit Fed Petroleum Contaminated Diet. European Journal of Scientific Research 2005;12:1-8   Back to cited text no. 11    
12.Iaccarino M, Boeri E, Scardi V. Preparation of Purified 3-Hydroxyanthranilic Acid Oxidase from Rat and Ox Liver. Biochem J 1961; 78:65-9.  Back to cited text no. 12    
13.Fidelis I. Achuba. Effect of Vitamins C and E Intake on Blood Lipid Concentration, Lipid Peroxidation, Superoxide Dismutase and Catalase Activities in Rabbit Fed Petroleum Contaminated Diet: Pakistan Journal of Nutrition 2005; 4:330-5.  Back to cited text no. 13    
14.Ognjanoviæ BI, Pavloviæ SZ, Maletiæ SD, Zikiæ RV, Stajn AS, Radojiciæ RM, Saiciæ ZS, e t al. Protective Influence of Vitamin E on antioxidant defense system in the blood of rats treated with cadmium. Physiol Res 2003;52:563-70.  Back to cited text no. 14    
15.Ellman GL. Tissue sulfhydroxy groups. Arch Biochem Biophysics 1959; 82:70- 7.  Back to cited text no. 15    
16.McCord JM, Fridovich I. Superoxide dismutase. An enzyme functions of erythrocuprein (hemocuprein). J Biol chem. 1969;244:6049-55.  Back to cited text no. 16    
17.Lowry's OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265-75.  Back to cited text no. 17    
18.Omu AE, Fatinikun T, Mannazhath N, Abraham S. Significance of Simultaneous Determination of serum and seminal plasma a tocopherol and retinol I in infertile men by high - performance liquid chromatography. Andrologia 1999; 31:347-54.  Back to cited text no. 18    
19.Maeda H, Akaike T. Nitric oxide and Oxygen radicals in infection, inflammation and cancer. Biochemistry Mosc 1998;63:854-65.  Back to cited text no. 19    
20.Seven A, Civelek S, Inci E, Inci F, Korkut N, Burcak G. Evaluation of oxidative Stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem 1999;32: 369-73.  Back to cited text no. 20    
21.Wagner, GM, Lubin, BH, Ye Chiu DT. Oxidative damage to red Cells. Cellular Antioxidants Defence Mechanisms. Boca Raton: CRC Press; 1998.  Back to cited text no. 21    
22.Beevi SS, Rasheed MH, Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta 2007; 375:119-23.  Back to cited text no. 22    
23.Manju V, Kalaivani Sailaja J, Nalini N. Circulating Lipid Peroxidation Antioxidant Status in Cervical cancer patients a case control study. Clin Biochem 2002; 35:621-5.  Back to cited text no. 23    
24.Kim SY, Kim JW, Ko YS, Koo JE, Chung HY, Lee- Kim YC. Changes in lipid Peroxidation and Antioxidant trace elements in serum of women with cervical intraepithelial neoplasia and invasive cancer. Nutr Cancer 2003; 47:126 -30.  Back to cited text no. 24    
25.Ahmed MI, Fayed ST, Hossein H, Tash FM. Lipid Peroxidation and antioxidant status in human cervical carcinoma. Dis Markers 1999; 15:283-91.  Back to cited text no. 25    
26.Manoharan S, Kolanjappan K, Kayalvizhi M. Enhanced Lipid Peroxidation and Impaired Enzymic Antioxidant Activities in Erythrocytes of Patients with Cervical Carcinoma. Cell Mol Biol Lett 2004;9:699-707.  Back to cited text no. 26    
27.Murray RK. Red and white blood cells In: Harper's Biochemistry, Murray RK, Granner DK, Mayes PA and Rodwell VW editors. 24 th Ed. Singapore: Prentice-Hall International; 1998;733-8  Back to cited text no. 27    
28.Gonçalves TL, Erthal F, Corte CL, Müller LG, Piovezan CM, Nogueira CW, et al . Involvement of Oxidative stress in pre-malignant states of cervical cancer in women. Clin Biochem 2005; 38:1071-5.  Back to cited text no. 28    


  [Table 1], [Table 2], [Table 3], [Table 4]

This article has been cited by
1 Plasma antioxidant capacity in cervical cancer patients
Anais da Academia Brasileira de Ciências. 2022; 94(2)
[Pubmed] | [DOI]
2 Dietary Total Antioxidant Capacity (TAC) Significantly Reduces the Risk of Site-Specific Cancers: An Updated Systematic Review and Meta-Analysis
Mahdieh Abbasalizad Farhangi, Mahdi Vajdi
Nutrition and Cancer. 2021; 73(5): 721
[Pubmed] | [DOI]
3 Oxidative damage and antioxidants in cervical cancer
Daciele Paola Preci, Angélica Almeida, Anne Liss Weiler, Maria Luiza Mukai Franciosi, Andréia Machado Cardoso
International Journal of Gynecologic Cancer. 2021; 31(2): 265
[Pubmed] | [DOI]
4 Molecular Tumor Subtypes of HPV-Positive Head and Neck Cancers: Biological Characteristics and Implications for Clinical Outcomes
Tingting Qin, Shiting Li, Leanne E. Henry, Siyu Liu, Maureen A. Sartor
Cancers. 2021; 13(11): 2721
[Pubmed] | [DOI]
5 A study of oxidative stress in cervical cancer- an institutional study
Kulsoom Zahra, Sandeep Patel, Tulika Dey, Uma Pandey, Surendra Pratap Mishra
Biochemistry and Biophysics Reports. 2021; 25: 100881
[Pubmed] | [DOI]
6 An assessment of serum oxidative stress and antioxidant parameters in patients undergoing treatment for cervical cancer
Anju Shrivastava, Surendra Pratap Mishra, Satyajit Pradhan, Sunil Choudhary, Saurav Singla, Kulsoom Zahra, Lalit Mohan Aggarwal
Free Radical Biology and Medicine. 2021; 167: 29
[Pubmed] | [DOI]
7 Lipid metabolism and oxidative stress in HPV-related cancers
Alfredo Cruz-Gregorio, Ana Karina Aranda-Rivera, Ariadna Jazmin Ortega-Lozano, José Pedraza-Chaverri, Francisco Mendoza-Hoffmann
Free Radical Biology and Medicine. 2021; 172: 226
[Pubmed] | [DOI]
8 The Preventive Effect of Dietary Antioxidants on Cervical Cancer Development
Ayumi Ono, Masafumi Koshiyama, Miwa Nakagawa, Yumiko Watanabe, Eri Ikuta, Keiko Seki, Makiko Oowaki
Medicina. 2020; 56(11): 604
[Pubmed] | [DOI]
9 Ingesta de antioxidantes y su asociación a Cáncer Cervicouterino en mujeres de un Sistema Universitario
Olivia González Acevedo, Pablo Zermeño Ugalde, Veronica Gallegos García, Lorena Díaz de León Martínez, Darío Gaytán Hernández
RESPYN Revista de Salud Pública y Nutrición. 2020; 19(1)
[Pubmed] | [DOI]
10 Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma
Ana Todorovic,Snežana Pejic,Ljubica Gavrilovic,Ivan Pavlovic,Vesna Stojiljkovic,Nataša Popovic,Snežana B. Pajovic
Antioxidants. 2019; 8(4): 97
[Pubmed] | [DOI]
11 Sera total oxidant/antioxidant status in lung cancer patients
Miao Xiang,Jiafu Feng,Lidan Geng,Yuwei Yang,Chunmei Dai,Jie Li,Yao Liao,Dong Wang,Xiao-Bo Du
Medicine. 2019; 98(37): e17179
[Pubmed] | [DOI]
12 Oxidative stress in cervical cancer pathogenesis and resistance to therapy
Safieh Ebrahimi,Arash Soltani,Seyed Isaac Hashemy
Journal of Cellular Biochemistry. 2019; 120(5): 6868
[Pubmed] | [DOI]
13 Melatonin: A new inhibitor agent for cervical cancer treatment
Rana Shafabakhsh,Russel J. Reiter,Hamed Mirzaei,Somayyeh Noei Teymoordash,Zatollah Asemi
Journal of Cellular Physiology. 2019;
[Pubmed] | [DOI]
14 Tissue Indices of Telomere Length and p53 in Patients with Different Gastrointestinal Tumors: Correlation with Clinicopathological Status
Hala M. ElBadre,Reham I. El-Mahdy,Nahed A. Mohamed,Madeha M. Zakhary,Doaa W. Maximous
Applied Biochemistry and Biotechnology. 2018; 186(3): 764
[Pubmed] | [DOI]
15 Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy
Dharambir Kashyap,Ajay Sharma,Katrin Sak,Hardeep Singh Tuli,Harpal Singh Buttar,Anupam Bishayee
Life Sciences. 2018; 194: 75
[Pubmed] | [DOI]
16 Association of CYBA gene (-930 A/G and 242 C/T) polymorphisms with oxidative stress in breast cancer: a case-control study
Mohini A. Tupurani,Chiranjeevi Padala,Kaushik Puranam,Rajesh K. Galimudi,Keerthi Kupsal,Nivas Shyamala,Srilatha Gantala,Ramanjaneyulu Kummari,Sanjeeva K. Chinta,Surekha R. Hanumanth
PeerJ. 2018; 6: e5509
[Pubmed] | [DOI]
17 Oxidative stress: therapeutic approaches for cervical cancer treatment
Gabriela Ávila Fernandes Silva, Rafaella Almeida Lima Nunes, Mirian Galliote Morale, Enrique Boccardo, Francisco Aguayo, Lara Termini
Clinics. 2018; 73: e548s
[Pubmed] | [DOI]
18 Significance of Serum Total Oxidant/Antioxidant Status in Patients with Colorectal Cancer
Rong Wu,Jiafu Feng,Yuwei Yang,Chunmei Dai,Anyang Lu,Jie Li,Yao Liao,Miao Xiang,Qingmei Huang,Dong Wang,Xiao-Bo Du,Reza Khodarahmi
PLOS ONE. 2017; 12(1): e0170003
[Pubmed] | [DOI]
19 Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies
Xiaoli Hu,Saisai Li,Lulu Zhou,Menghuang Zhao,Xueqiong Zhu,Lu-Zhe Sun
PLOS ONE. 2017; 12(8): e0183395
[Pubmed] | [DOI]
20 Oxidative Stress and Mitochondrial Dysfunction across Broad-Ranging Pathologies: Toward Mitochondria-Targeted Clinical Strategies
Giovanni Pagano,Annarita Aiello Talamanca,Giuseppe Castello,Mario D. Cordero,Marco d’Ischia,Maria Nicola Gadaleta,Federico V. Pallardó,Sandra Petrovic,Luca Tiano,Adriana Zatterale
Oxidative Medicine and Cellular Longevity. 2014; 2014: 1
[Pubmed] | [DOI]
21 Defective antioxidant systems in cervical cancer
Bin Jiang,Songshu Xiao,Md. Asaduzzaman Khan,Min Xue
Tumor Biology. 2013; 34(4): 2003
[Pubmed] | [DOI]
22 Superoxide dismutase isoenzyme activities in plasma and tissues of Iraqi patients with breast cancer
Hasan, H.R. and Mathkor, T.H. and Al-Habal, M.H.
Asian Pacific Journal of Cancer Prevention. 2012; 13(6): 2571-2576
23 Superoxide Dismutase Isoenzyme Activities in Plasma and Tissues of Iraqi Patients with Breast Cancer
Hathama Razooki Hasan,Thikra Hasan Mathkor,Mohammed Hasan Al-Habal
Asian Pacific Journal of Cancer Prevention. 2012; 13(6): 2571
[Pubmed] | [DOI]
24 HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress
Vonetta M Williams,Maria Filippova,Ubaldo Soto,Penelope J Duerksen-Hughes
Future Virology. 2011; 6(1): 45
[Pubmed] | [DOI]
25 Effects of thymus sipyleus and taurine on hepatic MDA, GSH, AOPP levels and SOD activity in ehrlich acide solid tumor model generated mice [Ehrlich asit solid tümör modeli oluşturulmu̧ farelerde thymus sipyleus ve taurinin karaciǧer MDA, GSH, AOPP düzeylerine ve SOD aktivitesine etkileri]
Turna, G. and Kiliç, N. and Yildirim, Z. and Sari, S.
Turkiye Klinikleri Journal of Medical Sciences. 2011; 31(5): 1153-1159
26 HPV-DNA integration and carcinogenesis: Putative roles for inflammation and oxidative stress
Williams, V.M. and Filippova, M. and Soto, U. and Duerksen-Hughes, P.J.
Future Virology. 2011; 6(1): 45-57
27 A common carcinogen benzo[a]pyrene causes p53 overexpression in mouse cervix via DNA damage
Meili Gao, Yongfei Li, Ying Sun, Jiangang Long, Yu Kong, Shuiyun Yang, Yili Wang
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2011;
[VIEW] | [DOI]
28 Hypoxia and oxidative stress in the pathogenesis of gynecological cancers and in therapeutical options
Karihtala, P., Puistola, U.
Current Cancer Therapy Reviews. 2011; 7(1): 37-55
29 Mitochondrial decay is involved in BaP-induced cervical damage
Gao, M., Long, J., Li, Y., Shah, W., Fu, L., Liu, J., Wang, Y.
Free Radical Biology and Medicine. 2010; 49(11): 1735-1745
30 Mitochondrial decay is involved in BaP-induced cervical damage
Meili Gao,Jiangang Long,Yongfei Li,Walayat Shah,Ling Fu,Jiankang Liu,Yili Wang
Free Radical Biology and Medicine. 2010; 49(11): 1735
[Pubmed] | [DOI]
31 Analysis of cervical supernatant samples luminescence using 355 nm laser
Vaitkuviene, A., Gegzna, V., Kurtinaitiene, R., Stanikunas, R., Rimiene, J., Vaitkus, J.
AIP Conference Proceedings. 2010; 1226: 96-104
32 Indole-3-carbinol inhibits nasopharyngeal carcinoma
Zhu, W., Li, W., Yang, G., Zhang, Q., Li, M., Yang, X.
International Journal of Toxicology. 2010; 29(2): 185-192
33 Indole-3-Carbinol Inhibits Nasopharyngeal Carcinoma
Wei Zhu,Wenxue Li,Guangyu Yang,Quanxin Zhang,Ming Li,Xingfen Yang
International Journal of Toxicology. 2010; 29(2): 185
[Pubmed] | [DOI]


Print this article  Email this article
Previous article Next article


  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow